High Cost of IPF Therapies Tied to 'Substantial Economic Burden'

... (around $12,888), with the anti-fibrotic therapies Esbriet (pirfenidone) and Ofev (nintedanib) accounting for nearly 85% of total ILD medication costs.

Source link